New York, October 16, 2014 --
Moody's Investor Service today downgraded Walgreen Co. senior
unsecured notes rating to Baa2. At the same time, Moody's
affirmed Walgreen's commercial paper rating at Prime-2. The
rating outlook is stable. This rating action concludes the
review for downgrade that was initiated on August 6, 2014.
RATINGS RATIONALE
The downgrade acknowledges that
Walgreen's debt to EBITDA will remain above 3.5 times for the
next three years following its acquisition of the remaining
55% stake of Alliance Boots in early 2015, its $3 billion
share repurchase program that will be completed by the end of
fiscal 2016, and its reduced 2016 EPS guidance.
Moody's estimates that Walgreen's
debt levels will increase from $4.5 billion currently to
between $17 billion and $19 billion following the closing of
the Alliance Boots transaction and the $3 billion share
repurchase program. This will result in debt to EBITDA
increasing in 2015 to about 4.25 times following the
acquisition and Walgreen borrowing to fund the $3 billion
share repurchase program. However, Moody's believes leverage
will improve starting in 2016 as Moody's expects Walgreen to
repay about $2.0 to $2.3 billion in debt in 2016, bringing
debt to EBITDA to between 3.75 times and 4.0 times by the end
of fiscal 2016. Moody's anticipates that Walgreen will make
about $2 billion in additional debt repayments in 2017 such
that its debt to EBITDA will remain below 3.75 times going
forward.
The following rating is downgraded
Senior unsecured rating to Baa2
from Baa1
The following rating is affirmed
Commercial paper rating at Prime-2
A new holding company will be
formed in connection with Walgreen's purchase of the remaining
55% stake of Alliance Boots, named Walgreens Boots Alliance
Inc. ("combined Walgreens Boots").
Walgreen's senior unsecured rating
reflects its strong market position as the largest drug store
operator in the United States. It also acknowledges the strong
market position of two of Alliance Boots three existing lines
of business; Boots, Alliance Healthcare, and Farmacias Ahumada.
Boots is the United Kingdom's largest drugstore retailer and
Alliance Healthcare is a leading European pharmaceutical
wholesaler. Farmacia Ahumada has a weaker competitive position
with Farmacias Benavides being the third largest retail
pharmacy chain in Mexico and Farmacias Ahumada being one of
the three largest retail pharmacy chains in Chile. The rating
is also reflective of the ten year contract with
AmerisourceBergen which should benefit earnings over the long
term. We believe the enhanced scalability of the Amerisource
Bergen partnership will create further purchasing power.
The rating also indicates our
favourable view of the drugstore industry. We believe the
drugstore industry will benefit from the aging of the U.S.,
U.K., and European populations which will likely drive
increasing use of prescription drugs over the long term. We
also believe the demand for prescription drug medication is
somewhat resilient to recessionary pressures. However, we view
negatively that the Mexican economy has been struggling with
weak growth.
The rating is constrained by the
combined Walgreens Boots' debt to EBITDA which will remain
high for the Baa2 rating for twelve to eighteen months
following the close of the acquisition. We anticipate that the
combined Walgreens Boots' debt to EBITDA will not return to
levels indicative of the Baa2 rating until after August 2016.
The rating is also constrained by our view that margins will
remain pressured by reimbursement rates worldwide, competition
in the European wholesale market, and selective generic drug
price inflation.
The stable outlook acknowledges
Moody's expectation that debt to EBITDA for combined Walgreens
Boots will improve to below 3.75 times by fiscal 2017.
Downward rating pressure would
develop should Walgreen pursue any further debt financed
shareholder activities or acquisitions. Ratings could be
downgraded should the combined Walgreens Boots operating
performance falter or should the combined entity be unable to
substantially reduce its debt levels over the twelve to
eighteen month period following the close of the transaction
such that debt to EBITDA does not approach 3.75 times by the
fiscal year ended August 2016. Ratings could also be
downgraded should Walgreen's choose to maintain debt to EBITDA
over 3.75 times over the longer term or should EBITA to
interest expense fall below 4.75 times.
Given the recent downgrade and the
weakness in credit metrics after the remaining equity stake in
Alliance Boots is acquired, an upgrade is unlikely at the
present time. Over the longer term ratings could be upgraded
should the combined Walgreens Boots operating performance
improve and debt be reduced such that debt to EBITDA falls to
3.25 times or below and should EBITA to interest expense
remain above 5.5 times. An upgrade would also require combined
Walgreens Boots to maintain a financial policy that supports
credit metrics remaining at this levels.
The principal methodology used in
this rating was Global Retail Industry published in June 2011.
Please see the Credit Policy page on www.moodys.com for a copy
of this methodology.
Walgreen Company, headquartered in
Deerfield, Illinois, operates over 8,200 drugstores in all 50
states, the District of Columbia, Guam, and Puerto Rico. It
also operates over 700 worksite health centers and wellness
clinics along with home care facilities. Revenues are over $76
billion. Alliance Boots, incorporated in Switzerland, is 45%
owned by Walgreen's and is a pharmacy-led health and beauty
retailer and pharmaceutical wholesaler in the United Kingdom
and throughout Europe. Alliance Boots revenues are about GBP23
billion. The combined Walgreen Boots Alliance Inc. revenues
are over $113 billion.
REGULATORY DISCLOSURES
For ratings issued on a program,
series or category/class of debt, this announcement provides
certain regulatory disclosures in relation to each rating of a
subsequently issued bond or note of the same series or
category/class of debt or pursuant to a program for which the
ratings are derived exclusively from existing ratings in
accordance with Moody's rating practices. For ratings issued
on a support provider, this announcement provides certain
regulatory disclosures in relation to the rating action on the
support provider and in relation to each particular rating
action for securities that derive their credit ratings from
the support provider's credit rating. For provisional ratings,
this announcement provides certain regulatory disclosures in
relation to the provisional rating assigned, and in relation
to a definitive rating that may be assigned subsequent to the
final issuance of the debt, in each case where the transaction
structure and terms have not changed prior to the assignment
of the definitive rating in a manner that would have affected
the rating. For further information please see the ratings tab
on the issuer/entity page for the respective issuer on
www.moodys.com.
For any affected securities or
rated entities receiving direct credit support from the
primary entity(ies) of this rating action, and whose ratings
may change as a result of this rating action, the associated
regulatory disclosures will be those of the guarantor entity.
Exceptions to this approach exist for the following
disclosures, if applicable to jurisdiction: Ancillary
Services, Disclosure to rated entity, Disclosure from rated
entity.
Regulatory disclosures contained
in this press release apply to the credit rating and, if
applicable, the related rating outlook or rating review.
Please see www.moodys.com for any
updates on changes to the lead rating analyst and to the
Moody's legal entity that has issued the rating.
Please see the ratings tab on the
issuer/entity page on www.moodys.com for additional regulatory
disclosures for each credit rating.
Margaret Taylor
VP - Senior Credit Officer
Corporate Finance Group
Moody's Investors Service, Inc.
250 Greenwich Street
New York, NY 10007
U.S.A.
JOURNALISTS: 212-553-0376
SUBSCRIBERS: 212-553-1653
Janice Ann Hofferber
Associate Managing Director
Corporate Finance Group
JOURNALISTS: 212-553-0376
SUBSCRIBERS: 212-553-1653
Releasing Office:
Moody's Investors Service, Inc.
250 Greenwich Street
New York, NY 10007
U.S.A.
JOURNALISTS: 212-553-0376
SUBSCRIBERS: 212-553-1653